文献速递产科母胎医学

肥厚型与其他类型心肌病患者的分娩方式回顾性研究

A retrospective study of mode of delivery in patients with hypertrophic vs other forms of cardiomyopathy.
PubMed 文献 · Am J Obstet Gynecol MFM · 2026-08-20

本研究基于Premier医疗数据库2016-2020年1872例心肌病产妇,比较不同心肌病亚型的分娩方式与母体不良事件。肥厚型心肌病计划剖宫产较计划阴道分娩的严重母体发病率OR为3.73(1.56-13.57),实际剖宫产较阴道分娩OR为3.98(1.06-14.91);围产期心肌病产时剖宫产率34%、严重母体发病率32%最高,肥厚型最低(20%和7%)。

要点

  • 肥厚型心肌病计划剖宫产较计划阴道分娩严重母体发病率OR 3.73(1.56-13.57)
  • 所有心肌病亚型实际剖宫产较阴道分娩严重母体发病率均升高
  • 产时中转剖宫产者严重母体发病率高,为该人群最高风险

核心结论

  • 肥厚型心肌病尝试阴道分娩与较低发病率相关,但需前瞻性研究确认。
  • 需产时中转剖宫产的患者是风险最高的人群。

研究设计与样本

  • 回顾性队列研究,使用Premier Healthcare住院数据库。
  • 纳入2016-2020年妊娠25周后分娩、年龄12-55岁、诊断为心肌病的患者。
  • 共1872例分娩,按ICD-10编码分为肥厚型、扩张型、围产期及其他/未特指心肌病。

主要发现

  • 围产期心肌病产时剖宫产率34%、严重母体发病率32%最高;肥厚型最低(20%和7%)。
  • 扩张型、围产期及其他心肌病计划剖宫产与计划阴道分娩的严重母体发病率无显著差异。
  • 实际剖宫产较阴道分娩的严重母体发病率OR:肥厚型3.98(1.06-14.91)、扩张型4.05(1.64-10.00)、围产期2.47(1.50-4.07)、其他2.18(1.36-3.51)。

关键数值与推荐

  • 肥厚型心肌病计划剖宫产vs计划阴道分娩严重母体发病率OR 3.73(1.56-13.57)。
  • 扩张型心肌病计划剖宫产vs计划阴道分娩严重母体发病率OR 1.50(0.68-3.27)。
  • 围产期心肌病计划剖宫产vs计划阴道分娩严重母体发病率OR 1.32(0.87-2.03)。
  • 其他心肌病计划剖宫产vs计划阴道分娩严重母体发病率OR 0.80(0.51-1.24)。

临床怎么用

  • 多数心肌病患者推荐尝试阴道分娩,但肥厚型心肌病计划剖宫产与更高严重母体发病率相关。
  • 应特别关注产时需中转剖宫产的患者,因其严重母体发病率最高。

局限性

  • 回顾性研究,可能存在选择偏倚(如更重患者被选择剖宫产)。
  • 需前瞻性研究确定安全产程时间及非计划剖宫产的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A better understanding of optimal modes of delivery is important for guiding peripartum recommendations for patients with cardiomyopathy and may differ by cardiomyopathy type. OBJECTIVE: This study examines the association between mode of delivery and maternal morbidity events in patients with different types of cardiomyopathy: hypertrophic, dilated, peripartum, and other or unspecified. STUDY DESIGN: This retrospective cohort study used the Premier Healthcare inpatient database, including patients aged 12 to 55 years who gave delivered after 25 weeks' gestation with a diagnosis of cardiomyopathy between 2016 and 2020. Patients were categorized into hypertrophic, dilated, peripartum, or other or unspecified cardiomyopathy subtypes based on International Classification of Diseases, Tenth edition codes. Mode of delivery was classified as vaginal or cesarean. Cesarean delivery was further classified as planned or intrapartum cesarean delivery. The exposure was the intended mode of delivery to simulate real-life delivery planning decisions (vaginal delivery, both completed and intrapartum cesarean delivery, vs planned cesarean delivery). An analysis by actual mode of delivery was also performed (completed vaginal deliveries vs intrapartum cesarean delivery and planned cesarean delivery). Outcomes included severe maternal morbidity, blood transfusion, 90-day readmission, and inotrope use. Each outcome was analyzed by cardiomyopathy subtype. Statistical analyses included descriptive comparisons and multivariable logistic regression, adjusting for age, insurance type, and comorbidities. RESULTS: There were 1872 deliveries across all cardiomyopathy subtypes. Among the subtypes, the peripartum cardiomyopathy group displayed the highest rates of intrapartum cesarean delivery (34%) and severe maternal morbidity (32%), and the hypertrophic cardiomyopathy group displayed the lowest rates (20% and 7%, respectively). There were no significant differences in severe maternal morbidity among patients with dilated (odds ratio, 1.50 [0.68-3.27]), peripartum (odds ratio, 1.32 [0.87-2.03]), or other (odds ratio, 0.80 [0.51-1.24]) cardiomyopathy when comparing intended cesarean vs intended vaginal delivery. In contrast, in the hypertrophic cardiomyopathy group, the odds ratio was 3.73 [1.56-13.57] for severe maternal morbidity when comparing intended cesarean vs intended vaginal delivery. In the analysis by actual mode of delivery, all cardiomyopathy subgroups had greater odds of severe maternal morbidity in cesarean vs vaginal delivery: hypertrophic (odds ratio, 3.98 [1.06-14.91]), dilated (odds ratio, 4.05 [1.64-10.00]), peripartum (odds ratio, 2.47 [1.50-4.07]), and other (odds ratio, 2.18 [1.36-3.51]). Among patients who delivered via cesarean delivery, the odds of severe maternal morbidity were higher across all subgroups, and rates of severe maternal morbidity events among the group requiring intrapartum conversion to cesarean delivery were high, suggesting this population to be at the highest risk. CONCLUSION: Among patients with hypertrophic cardiomyopathy, a trial of labor was associated with lower morbidity compared with a planned cesarean delivery, implying either that more morbid patients were selected for cesarean or that cesarean delivery was uniquely less optimal than vaginal delivery for hypertrophic cardiomyopathy patients in comparison to other cardiomyopathies in this cohort. Although a trial of labor is the recommended mode of delivery for most patients with cardiomyopathy, patients at greatest risk are those who require intrapartum conversion to cesarean. Prospective studies are needed to determine the safe length of time in labor in these patients and the factors leading to unplanned cesarean delivery.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Meng ML, Acuff H, Champion C, et al. A retrospective study of mode of delivery in patients with hypertrophic vs other forms of cardiomyopathy. Am J Obstet Gynecol MFM. 2026. PMID: 42624402. doi:10.1016/j.ajogmf.2026.102095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。